The Director-General, National Agency for Food and Drug Administration and Control (NAFDAC), says Nigeria can attain self-sufficiency in the manufacturing of medicine if the right policies are made.
She made this assertion in a statement made available in Abuja on Wednesday, stating that “with an enabling business and regulatory environment, the country can meet the requirements of quality and safe medicines, regardless of the current transient economic travails.
Adeyeye said that the formulation of enabling policies, the expansion of NAFDAC’s ceiling list, new policy on establishment of Pharmaceutical Plants in Nigeria and the centralised GMP inspection for Pharma plants, was targeted at increasing and stimulating local production of medicines.
She added that the management also had the idea of promoting collaboration with regulatory institutions, “which led to the conduct.
She said that the impact of COVID-19 pandemic is still a fresh one, adding that Nigeria’s pharmaceutical sector was badly hit by the refusal of exporting nations to open their borders for global trade in Active Pharmaceutical Ingredients (APIs) and Finished Pharmaceutical Products (FPPs).
According to her, available objective evidence from NAFDAC’S record shows that over 20 newly registered local drug manufacturers have cumulatively invested over.
Join our twitter community :